MEI Pharma (MEIP) Stock Chart & Stock Price History → Obama’s Forever Term [exposed] (From Porter & Company) (Ad) Free MEIP Stock Alerts $3.15 +0.22 (+7.51%) (As of 05/17/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability MEI Pharma Stock Price Performance5 Day Performance+3.96%1 Month Performance-3.08%3 Month Performance-28.25%6 Month Performance-47.67%Year-To-Date Performance-45.69%1 Year Performance-57.89% Receive MEIP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MEI Pharma and its competitors with MarketBeat's FREE daily newsletter Email Address Ad True Market Insiders4 Cryptos BETTER than BitcoinFormer Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than BitcoinClick For My #1 FREE Crypto for 2024 MEIP Stock Chart for Saturday, May, 18, 2024 MEIP Chart by TradingView MEI Pharma Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024$2.93$3.15+7.51%$3.18$2.9613,284 shs$20.98 million05/16/2024$3.11$2.93-5.64%$3.31$2.8759,898 shs$19.51 million05/15/2024$3.16$3.11-1.74%$3.24$3.0729,026 shs$20.68 million05/14/2024$3.03$3.16+4.29%$3.24$3.0814,847 shs$21.05 million05/13/2024$3.02$3.03+0.33%$3.12$3.009,862 shs$20.18 million05/10/2024$3.07$3.01-1.95%$3.07$3.018,473 shs$20.06 million Get the Latest News and Ratings for MEIP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MEI Pharma and its competitors with MarketBeat's FREE daily newsletter. 05/09/2024$3.18$3.07-3.46%$3.15$3.0714,114 shs$20.46 million05/08/2024$3.13$3.18+1.60%$3.21$3.062,593 shs$20.86 million05/07/2024$3.20$3.13-2.19%$3.20$2.9925,096 shs$20.85 million05/06/2024$3.06$3.20+4.58%$3.30$3.0615,184 shs$21.31 million05/03/2024$3.06$3.06$3.19$3.0617,147 shs$20.39 million05/02/2024$3.06$3.06$3.19$3.0611,077 shs$20.38 million05/01/2024$3.05$3.06+0.33%$3.20$3.0114,455 shs$20.38 million04/30/2024$3.08$3.05-0.97%$3.08$3.021,964 shs$20.31 million04/29/2024$3.05$3.08+0.98%$3.17$3.029,142 shs$20.51 million04/26/2024$3.10$3.05-1.61%$3.15$3.038,066 shs$20.31 million04/25/2024$3.26$3.10-4.91%$3.26$3.1016,736 shs$20.65 million04/24/2024$3.33$3.26-2.17%$3.45$3.227,384 shs$21.72 million04/23/2024$3.37$3.33-1.12%$3.33$3.245,008 shs$22.19 million04/22/2024$3.25$3.37+3.69%$3.37$3.226,544 shs$22.44 million04/19/2024$3.25$3.25$3.30$3.2226,402 shs$21.65 million04/18/2024$3.34$3.25-2.69%$3.38$3.2512,047 shs$21.65 million04/17/2024$3.19$3.34+4.87%$3.44$3.209,083 shs$22.24 million04/16/2024$3.25$3.19-2.00%$3.44$3.1916,466 shs$21.21 million04/15/2024$3.27$3.25-0.61%$3.36$3.2313,289 shs$21.65 million04/12/2024$3.63$3.33-8.26%$3.79$3.2122,242 shs$22.18 million04/11/2024$3.76$3.63-3.46%$3.83$3.6135,864 shs$24.18 million04/10/2024$3.82$3.76-1.57%$3.84$3.7515,786 shs$25.04 million04/09/2024$3.83$3.82-0.26%$3.88$3.8010,873 shs$25.44 million04/08/2024$3.75$3.83+2.13%$3.88$3.7116,395 shs$25.51 million04/05/2024$3.95$3.75-5.06%$3.87$3.7510,395 shs$24.99 million04/04/2024$4.05$3.95-2.47%$4.06$3.8015,598 shs$26.31 million04/03/2024$4.00$4.05+1.25%$4.07$3.8525,108 shs$26.97 million04/02/2024$3.88$4.00+2.98%$4.11$3.8431,958 shs$26.64 million04/01/2024$4.00$3.88-2.90%$4.00$3.8552,886 shs$25.87 million03/29/2024$4.00$4.00$4.15$3.8113,334 shs$26.64 million03/28/2024$3.95$4.00+1.27%$4.15$3.8113,334 shs$26.64 million03/27/2024$3.86$3.95+2.33%$3.95$3.8610,288 shs$26.31 million03/26/2024$3.87$3.86-0.31%$3.90$3.5525,476 shs$25.71 million03/25/2024$3.83$3.87+1.10%$3.96$3.8117,817 shs$25.80 millionElon to Transform U.S. Economy? (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it.03/22/2024$3.63$3.83+5.51%$3.83$3.5528,028 shs$25.51 million03/21/2024$3.58$3.63+1.40%$3.80$3.6318,827 shs$24.18 million03/20/2024$3.72$3.58-3.76%$3.84$3.568,392 shs$23.85 million03/19/2024$3.72$3.72$3.91$3.688,531 shs$24.78 million03/18/2024$3.83$3.72-2.87%$4.09$3.6318,929 shs$24.78 million03/15/2024$3.92$3.83-2.30%$3.96$3.5825,431 shs$25.52 million03/14/2024$4.08$3.92-3.92%$4.16$3.8516,359 shs$26.11 million03/13/2024$4.15$4.08-1.69%$4.23$4.0814,743 shs$27.17 million03/12/2024$4.00$4.15+3.75%$4.18$4.0344,138 shs$27.64 million03/11/2024$3.80$4.00+5.26%$4.24$3.8481,992 shs$26.65 million03/08/2024$3.54$3.80+7.34%$3.85$3.4641,699 shs$25.31 million03/07/2024$3.69$3.54-4.07%$3.80$3.5139,671 shs$23.58 million03/06/2024$3.98$3.69-7.29%$4.01$3.6564,336 shs$24.59 million03/05/2024$4.24$3.98-6.13%$4.25$3.9835,659 shs$26.51 million03/04/2024$4.25$4.24-0.24%$4.28$4.2113,916 shs$28.24 million03/01/2024$4.15$4.25+2.41%$4.33$4.1515,816 shs$28.31 million02/29/2024$4.18$4.15-0.72%$4.32$4.1316,640 shs$27.64 million02/28/2024$4.18$4.18$4.30$4.1610,649 shs$27.84 million02/27/2024$4.26$4.18-1.88%$4.38$4.1820,214 shs$27.84 million02/26/2024$4.31$4.26-1.16%$4.42$4.2517,436 shs$28.37 million02/23/2024$4.21$4.31+2.38%$4.35$4.209,412 shs$28.71 million02/22/2024$4.42$4.21-4.75%$4.56$4.218,256 shs$28.04 million02/21/2024$4.38$4.42+0.91%$4.67$4.3512,586 shs$29.45 million02/20/2024$4.39$4.38-0.23%$4.48$4.1333,368 shs$29.17 million02/19/2024$4.39$4.39$4.68$4.2047,700 shs$29.24 million Related Companies: Orgenesis Stock Price Chart Lumos Pharma Stock Price Chart Alaunos Therapeutics Stock Price Chart Synlogic Stock Price Chart Benitec Biopharma Stock Price Chart BioVie Stock Price Chart Cumberland Pharmaceuticals Stock Price Chart NeuroBo Pharmaceuticals Stock Price Chart KALA BIO Stock Price Chart CytoMed Therapeutics Stock Price Chart Receive MEIP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for MEI Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MEIP) was last updated on 5/18/2024 by MarketBeat.com Staff From Our Partners[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders AllianceThe Presidential candidate you should REALLY be worried aboutStansberry ResearchProtect Your Bank Account Before It’s Too LateWeiss RatingsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressWhat’s Really Next for America…Porter & CompanyHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MEI Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.